SYNOVUS FINANCIAL CORP - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 129 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.

Quarter-by-quarter ownership
SYNOVUS FINANCIAL CORP ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$43,137
+36.1%
10,2220.0%0.00%
Q2 2023$31,688
+123.0%
10,2220.0%0.00%
Q1 2023$14,209
-30.1%
10,2220.0%0.00%
Q4 2022$20,342
-34.4%
10,222
-32.8%
0.00%
Q3 2022$31,000
-35.4%
15,2220.0%0.00%
-100.0%
Q2 2022$48,000
-23.8%
15,2220.0%0.00%0.0%
Q1 2022$63,000
-13.7%
15,2220.0%0.00%0.0%
Q4 2021$73,000
-9.9%
15,2220.0%0.00%0.0%
Q3 2021$81,000
+3.8%
15,2220.0%0.00%0.0%
Q2 2021$78,00015,2220.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Fosun International Ltd 19,552,001$433,859,00020.80%
BRIDGER MANAGEMENT, LLC 2,642,621$58,640,0003.39%
TPG Group Holdings (SBS) Advisors, Inc. 3,884,600$86,199,0001.10%
HUSSMAN STRATEGIC ADVISORS, INC. 125,000$2,774,0000.80%
HealthCor Management, L.P. 1,036,110$22,991,0000.76%
GW&K Investment Management, LLC 2,049,765$45,484,0000.73%
Bridge City Capital, LLC 50,434$1,119,0000.70%
TCW GROUP INC 2,521,064$55,942,0000.46%
FRONTIER CAPITAL MANAGEMENT CO LLC 2,876,367$63,827,0000.41%
Quadrant Capital Management, LLC 25,002$555,0000.35%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders